Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Sudden sensorineural hearing loss: systemic steroid therapy and the risk of glucocorticoid-induced hyperglycemia.

Rohrmeier C, Koemm N, Babilas P, Prahs P, Strutz J, Buettner R.

Eur Arch Otorhinolaryngol. 2013 Mar;270(4):1255-61. doi: 10.1007/s00405-012-2134-0. Epub 2012 Jul 28.

PMID:
22843065
2.

Defibrinogenation therapy for idiopathic sudden sensorineural hearing loss in comparison with high-dose steroid therapy.

Suzuki H, Furukawa M, Kumagai M, Takahashi E, Matsuura K, Katori Y, Shimomura A, Kobayashi T.

Acta Otolaryngol. 2003 Jan;123(1):46-50.

PMID:
12625572
3.

Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: basis for planning randomized controlled trials.

Plontke S, Löwenheim H, Preyer S, Leins P, Dietz K, Koitschev A, Zimmermann R, Zenner HP.

Acta Otolaryngol. 2005 Aug;125(8):830-9.

PMID:
16158529
4.

Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss.

Arslan N, Oğuz H, Demirci M, Şafak MA, İslam A, Kaytez SK, Samim E.

Otol Neurotol. 2011 Apr;32(3):393-7. doi: 10.1097/MAO.0b013e318206fdfa.

PMID:
21221047
5.

Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.

Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF.

Laryngoscope. 2007 Jan;117(1):3-15. Review.

PMID:
17202923
6.

Comparison of therapeutic results in sudden sensorineural hearing loss with/without additional hyperbaric oxygen therapy: a retrospective review of 465 audiologically controlled cases.

Liu SC, Kang BH, Lee JC, Lin YS, Huang KL, Liu DW, Su WF, Kao CH, Chu YH, Chen HC, Wang CH.

Clin Otolaryngol. 2011 Apr;36(2):121-8. doi: 10.1111/j.1749-4486.2011.02303.x.

PMID:
21414179
7.

Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.

Park MK, Lee CK, Park KH, Lee JD, Lee CG, Lee BD.

Otolaryngol Head Neck Surg. 2011 Dec;145(6):1016-21. doi: 10.1177/0194599811418169. Epub 2011 Aug 4.

PMID:
21817157
8.

Screening for diabetes in patients with inflammatory rheumatological disease administered long-term prednisolone: a cross-sectional study.

Burt MG, Willenberg VM, Petersons CJ, Smith MD, Ahern MJ, Stranks SN.

Rheumatology (Oxford). 2012 Jun;51(6):1112-9. doi: 10.1093/rheumatology/kes003. Epub 2012 Feb 12.

9.

Hyperglycemia after intratympanic dexamethasone treatment in a diabetic patient.

Gallegos-Constantino V, Cervera-Paz FJ, Salvador J, Ba FK, Perez-Fernandez N.

Rev Laryngol Otol Rhinol (Bord). 2011;132(3):153-5.

PMID:
22533068
10.

Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.

Plaza G, Herráiz C.

Otolaryngol Head Neck Surg. 2007 Jul;137(1):74-8.

PMID:
17599569
11.
12.

Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes.

Han CS, Park JR, Boo SH, Jo JM, Park KW, Lee WY, Ahn JG, Kang MK, Park BG, Lee H.

Otolaryngol Head Neck Surg. 2009 Nov;141(5):572-8. doi: 10.1016/j.otohns.2009.06.084. Epub 2009 Oct 1.

PMID:
19861193
13.

Efficacy of 3 different steroid treatments for sudden sensorineural hearing loss: a prospective, randomized trial.

Lim HJ, Kim YT, Choi SJ, Lee JB, Park HY, Park K, Choung YH.

Otolaryngol Head Neck Surg. 2013 Jan;148(1):121-7. doi: 10.1177/0194599812464475. Epub 2012 Oct 16. Erratum in: Otolaryngol Head Neck Surg. 2013 Jun;148(6):1064.

PMID:
23077155
14.

Oral versus short-term intratympanic prednisolone therapy for idiopathic sudden hearing loss.

Filipo R, Attanasio G, Russo FY, Cartocci G, Musacchio A, De Carlo A, Roukos R, De Seta E, Di Tillo G, Viccaro M, Sarnacchiaro P, Covelli E.

Audiol Neurootol. 2014;19(4):225-33. doi: 10.1159/000360069. Epub 2014 Jul 1.

PMID:
24992949
15.

Intratympanic dexamethasone for refractory sudden sensorineural hearing loss.

Hunchaisri N, Chantapant S, Srinangyam N.

J Med Assoc Thai. 2010 Dec;93(12):1406-14.

PMID:
21344803
16.

The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss.

Lee JB, Choi SJ, Park K, Park HY, Choo OS, Choung YH.

Eur Arch Otorhinolaryngol. 2011 Jun;268(6):833-9. doi: 10.1007/s00405-010-1476-8. Epub 2011 Jan 8.

PMID:
21221620
17.

Modified intratympanic treatment for idiopathic sudden sensorineural hearing loss.

Kara E, Cetik F, Tarkan O, Sürmelioğlu O.

Eur Arch Otorhinolaryngol. 2010 May;267(5):701-7. doi: 10.1007/s00405-009-1130-5. Epub 2009 Oct 28.

PMID:
19862543
18.

Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy.

Suzuki H, Hashida K, Nguyen KH, Hohchi N, Katoh A, Koizumi H, Ohbuchi T.

Laryngoscope. 2012 May;122(5):1154-7. doi: 10.1002/lary.23245. Epub 2012 Mar 23.

PMID:
22447636
19.

Hyperglycemia as a potential prognostic factor of idiopathic sudden sensorineural hearing loss.

Ryu OH, Choi MG, Park CH, Kim DK, Lee JS, Lee JH.

Otolaryngol Head Neck Surg. 2014 May;150(5):853-8. doi: 10.1177/0194599814521012. Epub 2014 Jan 30.

PMID:
24482347
20.

Intratympanic methylprednisolone as rescue therapy in sudden sensorineural hearing loss.

Raymundo IT, Bahmad F Jr, Barros Filho J, Pinheiro TG, Maia NA, Oliveira CA.

Braz J Otorhinolaryngol. 2010 Jul-Aug;76(4):499-509. English, Portuguese.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk